跳至主要内容
临床试验/CTRI/2024/05/066843
CTRI/2024/05/066843尚未招募2 期

A comparative study to evaluate the efficacy of Bala Guduchayadi Tail Nasya with or without oral administration of Khandasama Churana in the management of Ardhavbhedaka w.s.r to Migraine

Dayanand Ayurvedic College1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年5月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To evaluate the efficacy of Bala Guduchayadi Tail Nasya in the management of Ardhavbhedaka w.s.r. to Migraine

研究概览

简要总结

In this clinical trial,total 60 patients will be selected on the basis of sign and symptoms.These 60 patients will divided into 2 groups named Group A and Group B.In Group A, Bala Guduchayadi Tail Nasya will be given along with oral administration of Khandasama Churna and in Group B, Bala Guduchayadi Tail Nasya will be given and will conduct a clinical trial to evaluate the efficacy of Bala Guduchayadi Tail Nasya in the management of Ardhavbhedaka w.s.r. to Migraine; To evaluate the efficacy of Bala Guduchayadi Tail Nasya with oral administration of Khandasama Churna in the management of Ardhavbhedaka and To compare the efficacy of Nasya Karma with or without oral administration of Khandasama Churna in the management of Ardhavbhedaka.The total duration of study will be 18 months.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient who are willing for study.
  • Patients who fulfills the classical symtoms of Ardhaavbhedhaka (Migraine) and fulfilling ICHS criteria Patients of age more than 16 years and not more than 60 years irrespective of sex, religion & occupations will be selected for the study.
  •  Patients fit for Nasya.

排除标准

  • Patients not willing for study.
  •  Patients suffering from any other forms of headache apart from Ardhaavbhedhaka.
  •  Headaches secondary to medical conditions like Meningitis, Tumor, encephalitis, Spondylosis or any other intracranial lesions and Refractive errors etc.
  •  Patients with complications of Migraine e.g status migrainosus, migraine aura triggered seizure, probable migraine etc.

结局指标

主要结局

To evaluate the efficacy of Bala Guduchayadi Tail Nasya in the management of Ardhavbhedaka w.s.r. to Migraine

时间窗: 28 days

ï‚· To evaluate the efficacy of Bala Guduchayadi Tail Nasya with oral administration of Khandasama Churna in the management of Ardhavbhedaka

时间窗: 28 days

ï‚· To compare the efficacy of Nasya Karma with or without oral administration of Khandasama Churna in the management of Ardhavbhedaka

时间窗: 28 days

次要结局

  • To provide economic, easily manageable, permanent and adverse affect free treatment for migraine(28 days)

研究者

发起方
Dayanand Ayurvedic College
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Megha Pathak

Dayanand Ayurvedic college

研究点 (1)

Loading locations...

相似试验